Featured Stories World News Commentary Money Watch Multimedia Prison Planet U.S. News Science And Technology

Swine flu vaccine supplier has to pay back millions

  • Print The Alex Jones Channel Alex Jones Show podcast Prison Planet TV Infowars.com Twitter Alex Jones' Facebook Infowars store

Rajeev Syal and Sakshi Ojha
London Observer
Sunday, Oct 11th, 2009

A company producing swine flu vaccine for Britain has paid millions of pounds in out-of-court settlements after being accused of fraudulently overcharging for medicines.

Baxter, the US pharmaceutical giant, reached at least seven huge settlements over the past 12 months, some of them for millions of dollars. The company had been accused of fraud amid allegations that it had overpriced medicines by as much as 1,300%.

The disclosure comes days after Baxter’s vaccine, Celvapan H1N1, was given approval by the European Medicines Agency and will raise fears about the growing costs of the swine flu pandemic. Vaccines are expected to cost the government £155m over the next four years.

Baxter became involved in prolonged litigation after being accused of fraudulently overcharging Medicaid, the US health programme that provides a safety net for the poorest families. Executives from the company paid out $2m to the Kentucky state government this year. Jack Conway, the Kentucky attorney general, said: “All of this could have been easily avoided if Baxter… had done what the law requires: report truthful prices.

Full article here

Swine flu vaccine supplier has to pay back millions  260909banner 

This article was posted: Sunday, October 11, 2009 at 4:33 am





Infowars.com Videos:

Comment on this article

Comments are closed.

Watch the News

FEATURED VIDEOS
Ebola: Medical Martial Law? See the rest on the Alex Jones YouTube channel.

Keith Olbermann Trash Talks Drudge, Infowars In Bizarre Twitter Rant See the rest on the Alex Jones YouTube channel.

© 2013 PrisonPlanet.com is a Free Speech Systems, LLC company. All rights reserved. Digital Millennium Copyright Act Notice.